Skip to Main Content

Paper Details

Evaluation of Three Commercial SARS-CoV-2 Serologic Assays and Their Performance in Two-Test Algorithms.
J Clin Microbiol
41
2020
COVID-19, IgG, SARS, SARS-CoV, SARS-CoV-2, coronavirus disease 2019, patients, respiratory symptoms, serum, severe acute respiratory syndrome coronavirus 2, spike
Author NameAffiliation
Jochen K LennerzMassachusetts General Hospital and Harvard Medical School
Andrew E RosenbergMassachusetts General Hospital and Harvard Medical School
Andrew E RosenbergMassachusetts General Hospital and Harvard Medical School
  • 1 - 3

Datasets